2024-02-13T14:05:48-06:00 2023-03-31 420714325 RSM US LLP 19026 RIDGEWOOD PKWY STE 400 SAN ANTONIO TX 78259 990 2022-04-01 731008735 OKLAHOMA BLOOD INSTITUTE OKLA 4052975700 1001 N LINCOLN BLVD OKLAHOMA CITY OK 731043251 RANDALL STARK CFO/TREASURER 4052975700 2024-02-12 1 RANDALL STARK 999009999 0 JOSEPHINE BEHREND P00715390 2108286281 2024-02-12 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z RANDALL STARK 1001 N LINCOLN BLVD OKLAHOMA CITY OK 731043251 138804853 0 X WWW.OBI.ORG X 1977 OK TO BE THE DONOR TO PATIENT LIFELINES BY MEETING BLOOD TRANSFUSION AND HEALTH CARE NEEDS. 24 18 1356 4275 -34040 28969 528062 311891 132137754 134265943 176054 1643693 2242829 1910405 135084699 138131932 189416 244629 0 0 68215840 72962717 0 0 0 59970858 60112440 128376114 133319786 6708585 4812146 100987193 107891650 22815330 25463158 78171863 82428492 X OKLAHOMA BLOOD INSTITUTE'S (OBI) MISSION IS TO BE THE DONOR-TO-PATIENT LIFELINES BY PROVIDING OUR COMMUNITIES AND MEDICAL PARTNERS SECURITY BY MEETING BLOOD TRANSFUSION AND HEALTH CARE NEEDS. 0 0 81606621 117563442 SERVICE FEES FOR BLOOD PRODUCTS: AS THE SIXTH-LARGEST BLOOD CENTER IN THE U.S, OBI COLLECTS, TESTS, PROCESSES, AND DISTRIBUTES MORE THAN 450,000 LIFE-SAVING BLOOD PRODUCTS ANNUALLY IN 16 BLOOD DONATION CENTERS ACROSS OKLAHOMA, ARKANSAS, AND TEXAS. OUR COMPLEX TECHNOLOGICAL INFRASTRUCTURE AND RARE MEDICAL EXPERTISE ALLOW OBI TO PROVIDE SAFE AND ADEQUATE BLOOD TO PATIENTS AT MORE THAN 230 AREA HOSPITALS, MEDICAL FACILITIES, AND AIR AMBULANCES ACROSS ALL THREE STATES. OUR RIGOROUS SAFETY MEASURES AND THE TIRELESS EFFORTS OF OUR MEDICAL LABORATORY STAFF ENSURE THAT THE DONATED BLOOD IS SAFE AND AVAILABLE TO SAVE LIVES. 9589641 9262782 TESTING SERVICES: WHILE MANY BLOOD CENTERS OUTSOURCE THEIR TESTING, OBI MAINTAINS AN IN-HOUSE TESTING LABORATORY TO PROVIDE A RAPID RESPONSE TO PROCESSING UNITS. WITH EVERY DONATION, OUR DILIGENT LABORATORY STAFF PERFORMS MULTIPLE TESTS TO ENSURE BLOOD PRODUCTS ARE SAFE AND READY TO BE TRANSFUSED TO LOCAL PATIENTS. AS A FULLY LICENSED AND CERTIFIED LABORATORY, OBI MAINTAINS THE HIGHEST STANDARDS AND LEADS THE NATION IN APPLYING CUTTING-EDGE TECHNOLOGY TO CREATE THE SAFEST BLOOD PRODUCTS POSSIBLE. OBI'S TESTING LABORATORY PROVIDES A WIDE SCOPE OF SAFETY TESTING FOR SEVERAL BLOOD-BORN CONDITIONS, LIKE HIV, HEPATITIS C, AND WEST NILE VIRUS, TO ENSURE BLOOD PRODUCTS ARE OF THE HIGHEST QUALITY. IF ANY SAMPLE IS POSITIVE FOR THESE ISSUES, OUR STAFF WILL NOTIFY THE DONOR AND REFER THEM FOR ADDITIONAL TESTING AND TREATMENT. AFTER THE BLOOD SAMPLE HAS BEEN CLEARED, ADDITIONAL HEALTH SCREENING TESTING IS PERFORMED. FOR EXAMPLE, WE TEST THE CHOLESTEROL LEVEL OF EVERY DONOR AS PART OF OUR STANDARD DONATION PROCESS. 2884452 4399516 PATIENT CARE REVENUE: THERAPEUTIC APHERESIS SERVICES FOR PATIENTS AT AREA HOSPITALS ARE PROVIDED BY SPECIALLY TRAINED REGISTERED NURSES UNDER THE DIRECTION OF TRANSFUSION MEDICINE PHYSICIANS. PATIENTS UNDERGO TREATMENTS THAT REMOVE HARMFUL PROTEINS, CHEMICALS OR CELLS IN THE BLOOD THAT CONTRIBUTE TO A VARIETY OF LIFE-THREATENING DISEASES OR TRANSPLANT COMPLICATIONS. BASED ON PATIENTS' CONDITIONS, SPECIFIC OFFENDING AGENTS OR COMPONENTS OF THE BLOOD ARE ISOLATED AND IRRADIATED OR REMOVED. AFTER THIS INTRICATE PROCESSING, PATIENTS RECEIVE THEIR TREATED BLOOD TO RESTORE HEALTH. 19801586 244629 4883683 OTHER PROGRAM SERVICES: THESE OTHER PROGRAM SERVICES ARE BLOOD PRODUCT DERIVATIVES. DERIVATIVES ARE A PRODUCT MANUFACTURED FROM A RAW MATERIAL BYPRODUCT OF BLOOD COLLECTION. OBI COLLECTS THIS MATERIAL, WHICH IS UNUSABLE FOR BLOOD TRANSFUSION, AND DISTRIBUTES THIS BYPRODUCT TO PLASMA MANUFACTURERS WHICH, IN TURN, USE IT IN THE PRODUCTION OF A BIOLOGICAL DRUG. REVENUE FOR THIS PROGRAM IS $370,493 WITH OFFSETTING EXPENSES TOTALING $297,849. THE CELL THERAPY PROGRAM INVOLVES COLLECTIONS OF STEM CELLS AND CORD BLOOD FROM PATIENTS, TESTING, AND MANUFACTURING THE PRODUCTS FOR PATIENT USE. REVENUE FOR THIS PROGRAM IS $578,892 WITH OFFSETTING EXPENSES TOTALING $840,217. OBI MANAGES THE LIFE-SAVING BLOOD DONATIONS OF MORE THAN 200,000 PEOPLE IN THE REGION EACH YEAR. THESE UNITS OF BLOOD ARE EVENTUALLY DELIVERED TO PATIENTS ACROSS THE REGION, BUT NOT BEFORE UNDERGOING AN IMMENSE AMOUNT OF FDA-REGULATED PROCESSING AND TESTING FOR DONOR AND BLOOD RECIPIENT SAFETY. VOLUNTEER BLOOD DONORS GIVE WHAT CAN'T BE CREATED AND PROVIDED BY ANY OTHER MEANS. OBI RECRUITS DONORS AND PROVIDES SKILLED MEDICAL STAFF, TECHNOLOGY, AND FACILITIES TO COLLECT BLOOD FROM DONORS. LAB PROFESSIONALS UNDER THE MEDICAL SUPERVISION OF PHYSICIANS PREPARE THE BLOOD FOR TRANSFUSION AND ADMINISTER MULTIPLE SAFETY TESTS. ALL MUST BE DONE WITH UTMOST URGENCY AND AROUND THE CLOCK SINCE BLOOD HAS A VERY LIMITED TIME FOR USE. OBI ADMINISTERS FIVE LAYERS OF SAFETY PROCEDURES - BLOOD DONOR ELIGIBILITY STANDARDS, INDIVIDUAL SCREENING, LABORATORY TESTING, CONFIDENTIAL EXCLUSION OF DONATIONS AND DONOR RECORD CHECKS. EXTENSIVE COMPLIANCE AND TECHNICAL TENURE ARE REQUIRED TO GET BLOOD FROM A DONOR TO A PATIENT. BLOOD CENTERS ALSO WORK CLOSELY WITH GOVERNMENT AGENCIES AND OTHER ENTITIES ON QUALITY CONTROL AND TRACKING. AN ENTIRE TEAM MANAGES THE SUPPLY LOGISTICS WITH EVERY MEDICAL FACILITY SERVED SO THAT THEY HAVE THE RIGHT BLOOD AT THE RIGHT TIME FOR PATIENTS. THIS CAN FLUCTUATE GREATLY, EVEN WITHIN A FEW HOURS. COURIERS TRAVEL MORE THAN SIX MILLION MILES EACH YEAR TO TRANSPORT DONATED BLOOD TO CENTRAL LABS AND HOSPITALS WITH ACCURACY AND EFFICIENCY, LEAVING NO NEED UNMET, REGARDLESS OF THE SITUATION OR TRAVEL CONDITIONS. HOSPITALS AND PATIENTS ARE NOT CHARGED FOR THE DONATED BLOOD ITSELF. EXPENSES ARE RECOVERED THROUGH A SERVICE FEE FOR EMPLOYEE WAGES, FUEL, VEHICLES, ADVANCED TESTING EQUIPMENT AND BLOOD PROCESSING AS SUMMARIZED ABOVE. OBI'S FEES AND QUALITY HAVE MADE IT THE CHOSEN, SOLE SUPPLIER FOR MORE THAN 90 PERCENT OF OKLAHOMA'S BLOOD SUPPLY, AS WELL AS MORE THAN 40 ARKANSAS HOSPITALS, EIGHT HOSPITALS IN THE TEXOMA REGION AND MOST HOSPITALS IN THE TEXAS HIGH PLAINS REGION. IT REQUIRES 24/7, 365 DAYS-A-YEAR STAFFING AND OPERATIONS, MUCH LIKE AREA HOSPITALS. 19801586 244629 4883683 113882300 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 1 1 1 1 0 0 1 194 0 1 1356 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 24 18 0 0 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 1 0 OK X RANDALL STARK 4052975700 1001 N LINCOLN BLVD OKLAHOMA CITY OK 731043251 JOHN B ARMITAGE MD PRESIDENT & CEO 50.00 9.00 X X 762881 0 87834 JOHN ADAMS BOARD MEMBER UNTIL 9/2022 2.00 X 2500 0 0 FRANK BARNETT MD BOARD MEMBER 1.00 X 0 0 0 RICHARD BOATSMAN MD BOARD CHAIR 3.00 3.00 X X 0 0 0 LARRY BOOKMAN MD BOARD MEMBER 3.00 2.00 X 16620 0 0 SCOTT CALHOON MD BOARD MEMBER 2.00 X 1500 0 0 DAVID R CARPENTER BOARD VICE CHAIR 3.00 2.00 X X 0 0 0 DAVID A FLACK MD BOARD MEMBER 1.00 X 0 0 0 JAY ALLEN GREGORY MD BOARD MEMBER 1.00 X 0 0 0 JOE M HODGES BOARD MEMBER 2.00 X 2500 0 0 HENRY J HOOD BOARD MEMBER 1.00 1.00 X 12000 0 0 RANDAL CARL JUENGEL MD BOARD MEMBER 2.00 3.00 X 12000 0 0 GARY MITCHELL BOARD MEMBER 1.00 X 0 0 0 WH OEHLERT MD BOARD MEMBER 1.00 X 0 0 0 JUDY GOFORTH PARKER PHDRN BOARD MEMBER 1.00 X 0 0 0 GARY L PATZKOWSKY DO BOARD MEMBER 1.00 1.00 X 0 0 0 MICHELLE POWERS MD BOARD MEMBER 1.00 X 0 0 0 CRAIG SPERRY BOARD MEMBER 1.00 X 0 0 0 PAUL STOUT MD BOARD MEMBER 1.00 X 0 0 0 KYM KOCH-THOMPSON BOARD MEMBER 1.00 X 0 0 0 EVAN VINCENT BOARD MEMBER 1.00 1.00 X 11000 0 0 KRISTI R WEABER BOARD MEMBER 2.00 X 0 0 0 GARLAND WILKINSON BOARD MEMBER 2.00 X 0 0 0 THEODORE VIOLETT MD ASSOC BOARD MEMBER 1.00 X 0 0 0 DAVID HOLDEN MD BOARD MEMBER 1.00 X 0 0 0 SUMIT NANDA MD BOARD MEMBER UNTIL 1/1/2022 1.00 X 0 0 0 TINA IPE MD CHIEF MEDICAL OFFICER 50.00 X 365868 0 39810 KIMBERLY VAN ANTWERPEN CHIEF OPERATIONS OFFICER 50.00 X 297193 0 38963 RANDALL STARK CHIEF FINANCIAL OFFICER 50.00 9.00 X 293460 0 59916 CHARLES MOONEY VP BIO DEVELOPMENT 50.00 X 224396 0 47759 TAMARA WHITELEY VP COMM. RELATIONS & DONOR RECRUITMENT 50.00 X 214236 0 36085 LAURA MCCLANNAN VP QUALITY MANAGEMENT 50.00 X 208127 0 27214 JOHN MARCELLUS CHIEF INFORMATION OFFICER 50.00 X 199447 0 38792 REGINA GARDNER VP DONOR SERVICES 50.00 X 196916 0 29697 TERRY RIDENOUR VP CENTER ADMIN & OPS 50.00 X 196825 0 35528 JASON PADGHAM VP TECHNICAL OPERATIONS 50.00 X 174894 0 48742 MICHAEL STEVENSON MD ASSOCIATE MEDICAL DIRECTOR 50.00 X 296898 0 35280 DEBRA SMITH MD ASSC. MED. DIRECTOR THRU 6/2/2022 50.00 X 162006 0 17872 JERRY POTTER IT PROGRAM EXEC. THRU 1/7/2022 50.00 X 204363 0 16760 JOSEPH MCNEIL AVP-HUMAN RESOURCES 50.00 X 182079 0 40892 JUSTIN REDWINE CHIEF TECHNOLOGY OFFICER 50.00 X 172091 0 46275 TARA SCOTT AVP RECRUITMENT 50.00 X 154922 0 43833 MICHELLE STEWART CONTROLLER 50.00 X 142753 0 20704 JENNIFER CHAIN R&D DIRECTOR 50.00 X 133868 0 25993 MELISSA STUBBLEFIELD THERAPEUTIC SVCS MGR 50.00 X 133452 0 14173 EDEN L MANNING CONTACT CENTER DIRECTOR 50.00 X 132687 0 21522 JOHN KRISCHEL SVC DELIVERY DIRECTOR 50.00 X 128337 0 24325 5035819 0 797969 57 0 1 0 HENSON CONSTRUCTION CO PO BOX 3715 ENID OK 73702 CONSTRUCTION CONTRACTOR 1583084 BLUE CROSS AND BLUE SHIELD OF OKLAHOMA PO BOX 60545 OKLAHOMA CITY OK 73146 BENEFITS ADMINISTRATION 1502020 CASTON CONSTRUCTION 6701 N CLASSEN BLVD OKLAHOMA CITY OK 73116 CONSTRUCTION CONTRACTOR 1292953 UNITED MECHANICAL 117 NE 38TH TERRACE OKLAHOMA CITY OK 73105 FACILITY MAINTENANCE 485543 STANDLEY SYSTEMS PO BOX 660831 DALLAS TX 75266 COPIER RENTAL/SERVICE 344077 16 311891 311891 SERVICE FEES 900099 119168853 119168853 LABORATORY FEES 621990 9678225 9674158 4067 PATIENT CARE SERVICES FEES 900099 4399516 4399516 CELL THERAPY 900099 578892 578892 DERIVATIVES 900099 440457 440457 134265943 1210143 1210143 304841 342948 -38107 -38107 -38107 235297 528226 294182 35791 -58885 492435 433550 433550 REBATES 900099 1242903 1232513 10390 MISCELLANEOUS INCOME 900099 610600 520025 90575 FREIGHT REIMBURSED 900099 94909 94909 100 100 1948512 138131932 136109423 -34040 1744658 244629 244629 4870052 3068299 1801753 68019 68019 55609951 49946632 5663319 1728375 1575815 152560 5683076 5475823 207253 5003244 4415704 587540 196007 196007 115590 115590 10924 10924 1924121 1102256 821865 846589 172582 674007 683598 474972 208626 1263424 96294 1167130 4292968 1265443 3027525 619869 562226 57643 235234 225681 9553 6040185 4285962 1754223 523112 523112 SUPPLIES 29502608 29502608 EQUIPMENT REPAIR 3962606 2210512 1752094 MOTOR VEHICLES 2917934 2806297 111637 DONOR RECOGNITION 2581826 2484540 97286 4395845 3374894 1020951 133319786 113882300 19437486 0 1967 1967 28274373 22899615 16438472 19177290 657976 707040 5610031 5853889 1610747 1480533 98464833 56854079 36537354 41610754 3722075 3449713 8134198 12710849 100987193 107891650 15159408 13916076 930362 0 6725560 6482989 0 5064093 22815330 25463158 X 78171863 82428492 78171863 82428492 100987193 107891650 4812146 -555517 0 X 0 1 X 1 0 X 245775 932743 1199773 528062 311891 3218244 107784640 115130901 143398013 134322220 136109423 636745197 108030415 116063644 144597786 134850282 136421314 639963441 6750 3900 17050 27700 46957097 48750728 43824363 54005638 57350362 250888188 46957097 48750728 43831113 54009538 57367412 250915888 389047553 91445 158420 35293 109730 1210143 1605031 91445 158420 35293 109730 1210143 1605031 54235 74709 77622 8574 0 215140 454356 560404 90449 42601 100965 1248775 108630451 116857177 144801150 135011187 137732422 643032387 0.60500 0.60510 0.00250 0.00070 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: PATRONAGE DIVIDENDS - 2018 AMOUNT: $ 316,753. 2019 AMOUNT: $ 323,660. REBATES - 2018 AMOUNT: $ 43,013. 2019 AMOUNT: $ 65,169. 2020 AMOUNT: $ 86,881. 2021 AMOUNT: $ 18,552. 2022 AMOUNT: $ 10,390. MISCELLANEOUS INCOME - 2018 AMOUNT: $ 94,590. 2019 AMOUNT: $ 171,575. 2020 AMOUNT: $ 3,568. 2021 AMOUNT: $ 24,049. 2022 AMOUNT: $ 90,575. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 811593 811593 19918992 9944586 9974406 27027675 15834318 11193357 47823445 31075175 16748270 2883128 2883128 41610754 FUNDS HELD BY COMMUNITY FOUNDATION 6851837 OTHER INVESTMENTS 757584 DEPOSITS 49642 OPERATING LEASE RIGHT-OF-USE ASSETS 5051786 12710849 LEASE LIABILITIES 5064093 5064093 X PART X, LINE 2: THE COMPANY FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS MORE THAN LIKELY NOT TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. THE COMPANY HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX-EXEMPT STATUS; TO IDENTIFY AND REPORT UNRELATED INCOME; TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT HAS NEXUS; AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. THE COMPANY HAS DETERMINED THAT THERE ARE NO OTHER MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. 1 GLOBAL BLOOD FUND 1001 N LINCLON BLVD OKLAHOMA CITY OK 73104 392071848 501(C)(3) 60224 0 GLOBAL BLOOD FUND: THIS CHARITY (OF WHICH OBI IS THE SOLE MEMBER) HAS A MISSION TO IMPROVE TRANSFUSION CARE IN THE DEVELOPING WORLD. THIS IS CONSIDERED A NATURAL EXTENSION OF OBI'S PURPOSE TO SAVE PATIENT LIVES THROUGH BLOOD PRODUCTS PROVIDED IN OUR LOCAL SETTINGS. DONATIONS PROVIDED ARE THE RESULT OF BLOOD DONORS CHOOSING TO FORGO RECEIVING A T-SHIT AFTER COMPLETING A DONATION AND ARE MADE AT A RATE LESS THAN THE COST OF THE T-SHIRT. OKLAHOMA BIOSCIENCE 840 RESEARCH PARKWAY 250 OKLAHOMA CITY OK 73104 452067346 501(C)(3) 6000 0 OKBIO PROMOTES THE GROWTH OF BIOSCIENCES AND LIFE SCIENCES IN OKLAHOMA THROUGH PARTNERSHIP BUILDING, EDUCATION AND OUTREACH, NETWORKING, POLICY DEVELOPMENT AND PUBLICITY. OKLAHOMA COUNTY MEDICAL SOCITY 313 N E 50TH SUITE 2 OKLAHOMA CITY OK 73105 730381790 501(C)(6) 10000 0 PROMOTE MEDICAL SCIENCE IN OKLAHOMA COUNTY. TULSA'S FUTURE INC ONE WEST THIRD ST 100 TULSA OK 74103 237033283 501(C)(3) 10000 0 THE MISSION IS TO SUPPORT THE TULSA REGIONAL CHAMBER OF COMMERCE IN LESSENING THE BURDENS OF THE MUNICIPAL GOVEEMENT OF THE CITY OF TULSA AS THE CITY ENDEVORS TO IMROVE ECONOMIC GROWTH IN THE TULSA METRO AREA. UNITED WAY OF CENTRAL OKLAHOMA PO BOX 248919 OKLAHOMA CITY OK 73124 730589829 501(C)(3) 6750 0 THIS CHARITY IS COMMITTED TO IMPROVING THE HEALTH, SAFETY, EDUCATION, AND ECONOMIC WELL-BEING OF INDIVIDUALS AND FAMILIES IN NEED IN CENTRAL OKLAHOMA BY CONNECTING COMMUNITY RESOURCES WITH RESPONSIVE AND ACCOUNTABLE HEALTH AND HUMAN SERVICES AGENCIES. OBI PROVIDED FUNDS TO HELP FURTHER THIS MISSION IN OUR LOCAL AREA. 4 1 PART I, LINE 2: DISTRIBUTIONS WILL BE MADE ONLY TO ESTABLISHED EXEMPT ORGANIZATIONS, RELYING ON THE REPORTS THAT SUCH ORGANIZATIONS PROVIDE. THE ORGANIZATION KEEP RECORDS OF ALL DISTRIBUTIONS MADE AND REQUIRE APPROPRIATE ACKNOWLEDGMENT FROM ALL ORGANIZATIONS TO WHOM IT RENDERS ASSISTANCE REGARDING THE USE OF FUNDS. X X X 1 1 0 0 0 0 0 1 0 JOHN B ARMITAGE MD PRESIDENT & CEO 680481 0 76400 0 6000 0 58000 0 29834 0 850715 0 0 0 TINA IPE MD CHIEF MEDICAL OFFICER 363868 0 1500 0 500 0 15000 0 24810 0 405678 0 0 0 RANDALL STARK CHIEF FINANCIAL OFFICER 291960 0 1250 0 250 0 29500 0 30416 0 353376 0 0 0 KIMBERLY VAN ANTWERPEN CHIEF OPERATIONS OFFICER 294943 0 2250 0 0 0 28715 0 10248 0 336156 0 0 0 MICHAEL STEVENSON MD ASSOCIATE MEDICAL DIRECTOR 243148 0 53750 0 0 0 22966 0 12314 0 332178 0 0 0 CHARLES MOONEY VP BIO DEVELOPMENT 223146 0 1250 0 0 0 21271 0 26488 0 272155 0 0 0 TAMARA WHITELEY VP COMM. RELATIONS & DONOR RECRUITME 210486 0 3250 0 500 0 20322 0 15763 0 250321 0 0 0 JOHN MARCELLUS CHIEF INFORMATION OFFICER 194497 0 4950 0 0 0 18864 0 19928 0 238239 0 0 0 LAURA MCCLANNAN VP QUALITY MANAGEMENT 202377 0 4250 0 1500 0 19078 0 8136 0 235341 0 0 0 TERRY RIDENOUR VP CENTER ADMIN & OPS 193575 0 3250 0 0 0 19722 0 15806 0 232353 0 0 0 REGINA GARDNER VP DONOR SERVICES 190166 0 4250 0 2500 0 19726 0 9971 0 226613 0 0 0 JASON PADGHAM VP TECHNICAL OPERATIONS 173144 0 1750 0 0 0 18705 0 30037 0 223636 0 0 0 JOSEPH MCNEIL AVP-HUMAN RESOURCES 180829 0 1250 0 0 0 23782 0 17110 0 222971 0 0 0 JERRY POTTER IT PROGRAM EXEC. THRU 1/7/2022 21305 0 0 0 183058 0 8025 0 8735 0 221123 0 0 0 JUSTIN REDWINE CHIEF TECHNOLOGY OFFICER 170841 0 1250 0 0 0 18473 0 27802 0 218366 0 0 0 TARA SCOTT AVP RECRUITMENT 150672 0 4250 0 0 0 17740 0 26093 0 198755 0 0 0 DEBRA SMITH MD ASSC. MED. DIRECTOR THRU 6/2/2022 136456 0 25550 0 0 0 12303 0 5569 0 179878 0 0 0 MICHELLE STEWART CONTROLLER 141503 0 1250 0 0 0 16436 0 4268 0 163457 0 0 0 JENNIFER CHAIN R&D DIRECTOR 130618 0 1250 0 2000 0 6869 0 19124 0 159861 0 0 0 EDEN L MANNING CONTACT CENTER DIRECTOR 128787 0 3900 0 0 0 7018 0 14504 0 154209 0 0 0 JOHN KRISCHEL SVC DELIVERY DIRECTOR 124087 0 4250 0 0 0 5921 0 18404 0 152662 0 0 0 PART I, LINES 4A-B OKLAHOMA BLOOD INSTITUTE PROVIDES A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN FOR CERTAIN EXECUTIVES. THERE WERE NO PAYMENTS DURING THE YEAR. THE FOLLOWING INDIVIDUALS PARTICIPATE IN A 457(F) PLAN: - JOHN B. ARMITAGE, MD - TINA IPE, MD - RANDALL STARK - KIMBERLY VAN ANTWERPEN - CHARLES MOONEY, JR JERRY POTTER RECEIVED A SEVERANCE PAYMENT OF $183,058. PART I, LINE 7 THE CEO HAS THE POTENTIAL OF EARNING A BONUS BASED ON CEO PERFORMANCE CRITERIA, REGULATORY COMPLIANCE, ORGANIZATIONAL GROWTH, MAINTAINING CUSTOMERS, ACQUIRING NEW CUSTOMERS, CUSTOMER SERVICE, PUBLIC PERCEPTION, AND ALLOWING NO SHORTAGE OF BLOOD PRODUCTS TO HOSPITAL CUSTOMERS. VIVIAN BROOKS ARMITAGE TOKARZ DAUGHTER OF OFFICER 39662 SALARY/BENEFITS 0 EMILY S PADGHAM DAUGHTER OF OFFICER 28201 SALARY/BENEFITS 0 JILL REDWINE WIFE OF KEY EMPLOYEE 17649 COMPENSATION FOR CONTRACT WORK 0 FORM 990, SCHEDULE L, PART IV: THE ABOVE BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS ARE PROVIDED TO OBI AT OR BELOW FAIR VALUE AND ARE IN THE NORMAL COURSE OF BUSINESS. ALL DECISIONS TO ENTER INTO THESE TRANSACTIONS WERE REVIEWED IN ACCORDANCE WITH OUR CONFLICT OF INTEREST POLICY AND THE INTERESTED PERSONS WERE EXCLUDED FROM THE DECISIONS MAKING PROCESS. FORM 990, PART VI, SECTION A, LINE 1A THE MEMBERS OF THE BOARD OF DIRECTORS OF OBI HOLDING COMPANY SHALL ALSO COMPRISE THE EXECUTIVE COMMITTEE OF THE CORPORATION, AND SHALL CONSIST OF THE CHAIRPERSON, VICE CHAIRPERSON, PRESIDENT AND FOUR OTHER MEMBERS OF THE BOARD OF DIRECTORS ELECTED BY A VOTE OF THE BOARD. THE EXECUTIVE COMMITTEE SHALL BE RESPONSIBLE FOR THE MANAGEMENT OF ALL FUNDS OF THE CORPORATION, SHALL HAVE AUTHORITY TO SUPERVISE, MANAGE, AND DIRECT ALL BUSINESS AFFAIRS OF THE CORPORATION AND SHALL ALSO DETERMINE THE NON-MEDICAL POLICIES OF THE CORPORATION, SUBJECT TO APPROVAL OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 6 OBI HOLDING COMPANY IS THE SOLE CORPORATE MEMBER OF OKLAHOMA BLOOD INSTITUTE (OBI) AND OBI FOUNDATION. AS SOLE CORPORATE MEMBER, OBI HOLDING COMPANY'S DUTIES INCLUDE (BUT ARE NOT LIMITED TO), ELECTION OF THE BOARD OF DIRECTORS AND PRESIDENT OF OBI. DIRECTORS OF OBI ARE LARGELY ELECTED AT THE ANNUAL MEETING OF THE CORPORATION. TWO DIRECTORS ARE APPOINTED BY TWO UNRELATED ASSOCIATIONS/SOCIETIES. ADDITIONALLY, OFFICERS AND MANAGEMENT OF THE ORGANIZATION ARE VESTED IN THE SAME INDIVIDUALS. FORM 990, PART VI, SECTION A, LINE 7A SEE DISCLOSURE FOR FORM 990, PART VI, SECTION A, LINE 6. FORM 990, PART VI, SECTION B, LINE 11B OBI HAS THE ANNUAL FORM 990 REVIEWED BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS IN A JOINT MEETING WITH THE COMPANY'S EXTERNAL AUDITORS PRIOR TO FILING. THE COMMITTEE RECEIVES A COPY OF THE FORM 990 PRIOR TO THE MEETING AND KEY SECTIONS ON GOVERNANCE, POLICIES, COMPENSATION, AND PROGRAM EXPENSES ARE REVIEWED. THE REVIEW IS COMPLETED, AND THE MEETING IS DOCUMENTED WITHIN THE MINUTES, WHICH BECOMES PART OF BOTH COMMITTEES' PERMANENT FILES. AT THE CONCLUSION OF THE REVIEW, THE ENTIRE BOARD IS PROVIDED A COPY OF THE FORM 990 PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C OBI'S CONFLICT OF INTEREST POLICY IS PROVIDED TO ALL BOARD MEMBERS AND OFFICERS ON AN ANNUAL BASIS, AND THEY ARE REQUIRED TO SIGN ANNUAL CONFLICT OF INTEREST AND CONFIDENTIALITY STATEMENTS EACH YEAR. EXECUTED COPIES OF THE CONFLICT OF INTEREST AND CONFIDENTIALITY STATEMENTS ARE MAINTAINED IN THE CORPORATE RECORDS AND THE CHAIR OF THE AUDIT/RISK MANAGEMENT COMMITTEE AND EXECUTIVE COMMITTEE ARE INFORMED OF ANY CONFLICTS DISCLOSED. IF A CONFLICT DOES EXIST, THE MEMBER WOULD RECUSE THEMSELVES FROM ANY VOTES OR DISCUSSIONS RELATED TO THE AREA OF CONFLICT. OBI MAINTAINS A CONFIDENTIAL DISCLOSURE HOTLINE AND WEBSITE THAT ALLOWS EMPLOYEES TO ANONYMOUSLY REPORT ANY CONCERNS OR POTENTIAL CONFLICTS OF INTEREST. ALL REPORTS ARE SENT THROUGH THE SENIOR H.R. EMPLOYEE, AND SIGNIFICANT ISSUES ARE FORWARDED TO THE CHAIR OF THE AUDIT/RISK MANAGEMENT COMMITTEE. FORM 990, PART VI, SECTION B, LINE 15 AS LEADERS OF THE STATE'S LARGEST BIOPHARMACEUTICAL ORGANIZATION, A 1000-PLUS STAFF ENTITY, THE ROLES OF CEO AND OTHER PHYSICIANS AND EXECUTIVES REQUIRE A RARE BLEND OF ASTUTE ORGANIZATIONAL LEADERSHIP, VISION, FIDUCIARY MANAGEMENT, ADVANCED MEDICAL SPECIALIZATION, AND EXPERTISE IN THE UNIQUE SCIENTIFIC FIELD OF TRANSFUSION MEDICINE. EXECUTIVES HAVE RESPONSIBILITY FOR 16 OPERATIONAL FACILITIES ACROSS 10 COLLECTION OPERATIONS IN THE REGION AND THE DAY-TO-DAY PROVISION OF A SAFE AND SUFFICIENT BLOOD SUPPLY TO MEET THE NEEDS OF PATIENTS IN MORE THAN 230 HOSPITALS SERVED. THE COMPENSATION OF THE CEO IS DETERMINED BY THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS COMPRISING COMMUNITY LEADERS, BUSINESS EXECUTIVES AND PHYSICIANS WITH EXEMPLARY ETHICAL AND FIDUCIARY STANDARDS. CEO COMPENSATION IS BASED ON COMPARATIVE SALARY DATA FROM SIMILAR HEALTH CARE ORGANIZATIONS USING IRS FORM 990S AND INDUSTRY SALARY SURVEYS. SIMILARLY, COMPENSATION FOR EXECUTIVES REPORTING TO THE CEO IS PROPOSED BY THE CEO BASED ON COMPARABLE NATIONAL AND LOCAL SALARIES FOR POSITIONS AND APPROVED BY THE EXECUTIVE COMMITTEE. CHANGES TO COMPENSATION ARE REVIEWED AND FORMALLY APPROVED BY THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 COPIES OF THE ORGANIZATION'S FORMS 990 AND 990-T ARE AVAILABLE TO THE PUBLIC UPON REQUEST. CONFLICT OF INTEREST AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. BIO-LINKED LLC 1001 NORTH LINCOLN BLVD OKLAHOMA CITY OK 73104 RESEARCH OK 20662 0 OBI HOLDING COMPANY OBI REAL ESTATE COMPANY II 1001 NORTH LINCOLN BLVD OKLAHOMA CITY OK 73104 731386765 REAL ESTATE OK 0 0 OBI HOLDING COMPANY CYTOGROWTH SOLUTION LLC 1001 NORTH LINCOLN BLVD OKLAHOMA CITY OK 73104 RESEARCH OK 0 0 OBI HOLDING COMPANY BLOOD INSTITUTE VENTURES LLC 1001 NORTH LINCOLN BLVD OKLAHOMA CITY OK 73104 274711286 INVESTMENTS OK 0 0 OBI HOLDING COMPANY OKLAHOMA BLOOD INSTITUTE FOUNDATION 1001 NORTH LINCOLN BLVD OKLAHOMA CITY OK 73104 311721750 SUPPORT ORG OK 501(C)(3) LINE 12B, II OBI HOLDING COMPANY 1 OBI HOLDING COMPANY 1001 NORTH LINCOLN BLVD OKLAHOMA CITY OK 73104 731386765 HOLDING CO OK 501(C)(3) LINE 10 N/A 0 GLOBAL BLOOD FUND 1001 NORTH LINCOLN BLVD OKLAHOMA CITY OK 73104 392071848 BLOOD SERVICES OK 501(C)(3) LINE 7 OBI HOLDING COMPANY 1 ALLIANCE FOR COMMUNITY TRANSFUSION SRV 2205 HIGHWAY 121 BEDFORD TX 76021 454624346 EFFICIENCY TX 501(C)(3) LINE 12B, II N/A 0 OKLAHOMA BLOOD INSTITUTE REAL ESTATE 1001 NORTH LINCOLN BLVD OKLAHOMA CITY OK 73104 731386856 REAL ESTATE OK 501(C)(25) OBI HOLDING COMPANY 1 THE EAST CENTRAL OKLAHOMA BLOOD INSTITUTE 1930 STONECIPHER BLVD ADA OK 74820 030389332 SUPPORT ORG OK OBI HOLDING COMPANY C 0 SOUTHERN OKLAHOMA BLOOD INSTITUTE 1420 VETERANS BLVD ARDMORE OK 73401 741541246 SUPPORT ORG OK OBI HOLDING COMPANY C 0 0 1 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 GLOBAL BLOOD FUND B 95422 FMV EAST CENTRAL OKLAHOMA BLOOD INSTITUTE J 92184 FMV PART IV: THE EAST CENTRAL OKLAHOMA BLOOD INSTITUTE AND SOUTHERN OKLAHOMA BLOOD INSTITUTE WERE ORGANIZED AS SUPPORTING ORGANIZATIONS OF OKLAHOMA BLOOD INSTITUTE. EACH ORGANIZATION IS IN PROCESS OF APPLYING FOR TAX-EXEMPT STATUS WITH THE IRS.